- Open Access
Induction of calcification by serum depletion in cell culture: a model for focal calcification in aortas related to atherosclerosis
© Hsu et al; licensee BioMed Central Ltd. 2008
- Received: 03 December 2007
- Accepted: 29 January 2008
- Published: 29 January 2008
Since aortic calcification has been shown to initiate in the lower zone of well-thickened plaques (LZP) adjacent to the aortic media of rabbits fed supplemental cholesterol diets, a restricted supply of serum to vascular cells could play a role in vascular calcification. This study was designed to use a cell culture model to support this hypothesis.
Rabbit aortic smooth muscle cells were grown to confluence in a culture media containing 10 % fetal bovine serum (FBS). The confluent cells were then exposed to the media for 2 hrs with or without serum at a Ca × P ion product range of 4.5–9.4 mM2. In contrast to the cells cultured in the presence of FBS, confluent cells in its absence displayed marked mineral-positive alizarin red staining and infrared absorption of mineral phosphate. A kinetic parameter C1/2 was used to designate the concentration of serum or its protein constituents needed to reduce the deposition of Ca and P by half. The C1/2 for FBS and rabbit serum was 0.04–0.07 % The C1/2 value for rabbit serum proteins was 13.5 μg/ml corresponding to the protein concentration in 0.06 % of serum. This C1/2 was markedly smaller than 86.2 μg/ml for bovine serum albumin present in 0.37 % serum (p < 0.05). Serum depletion also caused marked membrane translocation as evidenced through a specific apoptosis dye uptake by cells. The proteomic analysis of calcifying vesicles, which can be released by serum depletion, revealed several calcification-related proteins.
The aortic smooth muscle cell culture model suggests that serum depletion may play a role in the initiation of aortic calcification. The serum exhibits remarkable ability to inhibit cell-mediated calcification.
- Vascular Calcification
- Aortic Calcification
- Membrane Translocation
- Serum Depletion
- Thoracic Aortic Calcification
Clinical and epidemiological studies have implicated vascular calcification in myocardial infarction , instability and rigidity of the arterial wall , bioprosthetic valve failures , etc. In spite of the evidence that both physiological and pathological calcification is regulated through gene expressions of osteopontin (OPN) , matrix γ-carboxyglutamate protein (MGP) , and osteoprotegerin (OPG) , the mechanisms whereby calcium phosphate minerals are initially deposited in the arterial wall remain uncertain [7–9]. The issue of the involvement of the active process vs. passive process in atherosclerosis-related calcification was reviewed by Schinke et al. . This issue can be further complicated by the difficulty in separating the effects of the agents on nascent mineralization from those on mineral proliferation. The paradoxical nature of different hypotheses could stem from the lack of detailed information of the specific molecular events aiming at the earliest stage of calcification. The development of strategies for arresting the initial stage of calcification could be a crucial step in the prevention of further spread of unwanted calcification. One of the underlying mechanisms of vascular calcification was proposed to be tightly linked to osteogenesis [10, 11], since bone formation and calcification in human aortas were first described by Virchow in 1863  and later shown to be in human cardiac valves by Mohler and colleagues in 2001  both at the advanced stages of atherosclerosis. However, on the basis of genetic analyses and the rare occurrence of bone formation in human lesions, Schinke et al [8, 9] conceptualized the onset of vascular calcification as being related to a dystrophic process independent of osteogenesis. An alternative hypothesis for the participation of a remote bone resorption process in vascular calcification was advocated by Price and colleagues using hypervitamin D-treated rat model . This model was deduced from the observation that subcutaneous injections of specific bone resorption inhibitors such as bisphosphonates to the rat inhibited calcification in arterial media. Another interesting observation that may also underlie the cause of vascular calcification in human subjects was the finding of mineral-associated nanobacteria-like structures in advanced atherosclerotic aortic walls .
Induction of calcification in vitro by serum depletion
List of identified proteins related to calcification in calcifying vesicles from tadem spectrometry. Data were analyzed using a Biowors 3.2 (ThermoFinnigan) program.
Calpactin I Heavy chain
SNAQRQDIAFAYQR (2, 4.50, 0.32)
LSLEGDHSTPPSAYGSVK (2, 4.00, 0.40)
RAEDGSVIDYELIDQDAR (2, 3.69, 0.29)
GVDEVTIVNILTNR (1, 2.83, 0.29)
Calreticulin or CRP55
FYALSAR (1, 2.00, 0.44)
FKPFSNKGQPLVVQFTVK (2, 3.75, 0.64)
EPVVYFKEQFLDGDGWTER.G (2, 10.2, 0.54)
Integrin beta 1
SKGTAEKLQPEDITQIQPQQLVLQLR (1, 2.02, 0.36)
GTAEKLQPEDITQIQPQQLVLQLR (2, 5.42, 0.54)
LQPEDITQIQPQQLVLQLR (2, 5.42, 0.54)
SGEPQTFTLK (2, 2.02, 0.36)
IKGTQC#EDINEC#EVFPGVC#K (2, 3.00, 0.36)
IKGTQC#EDIDEC#EVFPGVCKNGLCVNTR (3, 4.58, 0.35)
ATPase β subunit
VALTGLTVAEYFRDEEGQDVLLFIDNIFR (3, 2.70, 0.27)
AIAELGIYPAVDPLDSTSR (2, 4.76, 0.12)
ITSTKEGSITSIQAIYVPADDLTDPAPATTFAHLDATTVLSR (3, 5.69, 0.17)
VLDSGAPIKIPVGPETLGR (2, 3.81, 0.65)
ILQDYKSLQDIIAILGMDELSEEDKLTVSR (3, 3.78, 0.55)
ILGADTSVDLEETGRVLSIGDGIAR (2, 3.26, 0.19)
TGAIVDVPVGEELLGRVVDALGNAIDGKGPIGSK (2, 5.13, 0.47)
AIAELGIYPAVDPLDSTSR (1, 3.0, 0.46)
A previous report in this laboratory demonstrated that unlike the control experiments in which abundant blood vessels with bone marrow were present in Saos-2 osteosarcoma extract-induced ectopic bones in nude mouse skeletal muscles, the lower zone of plaques (LZP) in atherosclerotic rabbit aortas lacked the evidence of vessel intrusions and bone formation . These observations suggest that the induction of LZP calcification could be caused by the restriction in blood supply to the LZP due to intimal thickening without a prerequisite osteogenesis [10, 11] or remote bone resorption . This contention was further supported by the present data obtained from the experimentation with cultured rabbit aortic smooth muscle cells exposed to serum depletion. In spite of the present in vitro model, factors that underlying the mechanism of the serum depletion-induced LZP calcification remains to be established. A reduced amount or a lack of some serum proteins in the LZP may play a role in LZP calcification. For example, anhydrase and hemoglobin are essential proteins in the regulation of blood pH and their absence could potentially influence pH dependent-mineralization process. The lack of hemoglobin may affect oxygen tension and could in theory alter acid-base chemistry through the isohydric shift, although the role of oxygen in LZP calcification has yet to be established. Moreover, potent mineralization inhibitors such as OPN  and MGP  in blood could be prevented from reaching LZP by intimal thickening. Other factors such as alterations in osmolarity, which can be affected by serum protein deletion, remain unknown. However, the present observation shows that much less amounts of whole serum proteins than serum albumin were needed to inhibit calcification, suggesting that change in osmolarity by serum depletion may not play a significant role in the calcification. An attempt to reproduce intimal thickening in vivo by the addition of cholesterol to SMC culture increased neither cell proliferation nor calcification (not shown). This is expected since aortic calcification in rabbits fed cholesterol diets did not occur until intima was extensively thickened [7, 18, 19].
The minimal requirement of Ca × P ion products of 5.0 mM2 in excess of the serum level of 3.5 mM2 for serum depletion-induced calcification in vitro suggests that additional mechanisms are needed to increase Ca and/or P in the LZP. The current experiments using a sensitive measurement of Ca with Arsenazo III dye  indicated that 5.02 ± 0.25 mM Ca (6 serum samples) was present in rabbit serum vs. 3.23 mM using an electrode assay procedure . A protein-free fraction of serum obtained from 10% trichloroacetic acid (TCA) precipitation followed by the removal of TCA through lyophilization yielded the same result (not shown). The precision and accuracy of the procedure was verified by the use of known quantities of calcium carbonate and calcium mono- or dibasic phosphate dissolved in 0.1 N HCl. Although the difference in quantities between the two procedures could be due to the technical issue, the data suggest a large pool of serum Ca available for calcification through the diffusion process. High ion products can be further achieved via the hydrolysis of phosphoesters in cells. High concentrations of β-glycerophosphate ranging from 5–10 mM were routinely used in numerous studies of calcification in cell cultures including bone cells  and bovine SMCs . However, the current data indicated that rabbit SMCs cultured for up to 14 day in the presence of 10% FBS and/or 10 mM β-glycerophosphate with a biweekly medium changes did not display calcification (data not shown). This is expected since rabbit SMCs and aortas neither have alkaline phosphatase activity nor the ability to hydrolyze β-glycerophosphate . The paradoxical difference in the effect of serum on calcification between rabbit and bovine SMCs remains to be established. Moreover, the Ca × P ion products needed to initiate mineralization with varying Ca and constant P levels appeared to be lower than those with constant Ca and varying phosphate levels (p < 0.05). The changes in FT-IR of amide peak after mineralization also suggest that the perturbation of protein absorption in the infrared spectrum could be attributable to Ca binding or by overlapping mineral deposits.
We previously reported that serum depletion in culture media increased the production of calcifying vesicles, which contain enzymes capable of hydrolyzing nucleotides including Ca-Mg ATPase, AMPase, ADPase, and nucleoside triphosphate pyrophosphohydrolase [21, 22]. The elevated enzyme activities could increase either Ca or P accumulation in favor of mineralization, . The present mass spectral data as shown in Table 1 demonstrate the presence of various calcification-related proteins in calcifying vesicles. These observations, therefore, further support the role of the release of these vesicles in vascular calcification [7, 19, 21, 22]. Furthermore, calcifying vesicles could be trapped and concentrated within LZP by intimal thickening, thereby promoting focal calcification. The ability of serum depletion to induce calcifying vesicles in SMCs is consistent with the observation that calcifying vesicles can be released from human osteosarcoma cells (Saos-2) within 30 min after exposure to serum-free media . Thus, the increased vesicle activity resulting from serum depletion in LZP and the availability of a large pool of serum Ca and/or P diffusible through LZP could provide a mechanism to surpass the threshold ion product needed for calcification.
Apoptotic bodies have been suggested to play a role in physiological and pathological calcification. The present observations of the association between serum-depletion-induced membrane translocation (MT), which is an early event of apoptosis and calcification suggest that the change in membrane topology may play a pivotal role in vascular calcification. Such contention is consistent with our observation that calcifying vesicles were accumulated on the surface of SMCs upon incubation with serum-free culture. The lack of association between peroxide-induced MT and cell-mediated calcification is likely due to the presence of serum in the MT assay, since the MT induced by serum depletion or peroxide can be fully reversed within 30 min by the serum replenishment (data not shown). The less degree of the dye uptake shown in Fig. 8A than in 8B was probably due to a partial inhibition of MT by the inclusion of serum in the assay for peroxide-induced MT. Thus, these data indicate that serum can inhibit both membrane translocation and calcification.
The marked inhibitory effect of extensively diluted serum indicates that minute quantities of some serum protein components play a pivotal role in LZP calcification. It appears from C1/2 data that serum albumin may need to synchronize with other serum proteins to produce maximal effect. Despite these experiments, the mechanisms underlying the inhibitory effect of the minute amounts of serum on calcification are unclear. In contrast to the preventive effect of serum on calcification in rabbit SMC culture reported herein, a rat model in which animals were injected with high dosage of vitamin D, the increase in fetuin-mineral complex level in rat serum was shown to correlate with arterial calcification in the media . The paradoxical differences in the effects of the serum on vascular calcification at the two distinct parts of the arteries between these two species are unclear. It is also plausible that some minor proteins in the serum with the ability to inhibit mineralization such as osteopontin (OPN) [29, 37], matrix γ-carboxyglutamate (Gla) protein (MGP) , and osteoprotegerin (OPG)  may play a major role in the serum effect. Giachelli and colleagues  demonstrated that OPN at a level of 50 ng/ml inhibited bovine SMCs in vitro calcification, which occurred after a 10-day exposure to the media containing 10% serum and 10 mM β-glycerophosphate. Since the effective concentration of OPN in these experiments was 5-fold higher than the serum OPN level , whether the serum level of OPN can inhibit serum depletion-induced calcification remains to be established. A direct test to see if OPN or MGP at the serum levels can inhibit calcification in the rabbit aortic SMC short-term cell cultures awaits the availability of purified proteins for testing. The purified recombinant OPN from EMP Genetech did not inhibit SMC calcification (not shown), probably due to insufficient phosphorylation in the recombinant protein. Since a range of 5–11 ng/ml of OPN was present in human sera , a comparison of C1/2 values among the total serum proteins and regulatory proteins could rule in or out whether one of these proteins is essential for the prevention of unwanted calcification. In addition, whether there is a need of synchronization with other essential proteins can be addressed by the comparison of C1/2 values among these proteins.
Altogether, the data from the in vitro cell culture experiments herein support the hypothesis that serum depletion in LZP imposed by lesion thickening could trigger calcification through the accumulation of calcifying vesicles on the cell surface  and/or the elimination of the potent serum mineralization inhibitors in the LZP. The short-term nature of the effect of serum depletion on calcification in cultures also suggests that the initial events of calcification in rabbit thoracic aortas during dietary cholesterol intervention are independent of osteogenesis and could be related to membrane translocation, an early event in apoptosis [7–9, 23].
The aortic smooth muscle cell culture model suggests that serum depletion may play an important role in the initiation of aortic calcification. The serum exhibits a remarkable ability to inhibit cell-mediated calcification.
Animals, culture reagents, and chemicals
DMEM, FBS, and all reagents for culture were obtained from GIBCO. Normal rabbit serum was a product of Sigma Chemicals Inc. For Ca and P determinations, serum samples were taken from the ear veins of normal rabbits kept in our animal facility center. Arsenazo III dye kit for Ca determination was purchased from Fischer Scientific. A standard phosphate assay kit was a product of Sigma Chemicals. Apoptosis assay kit was purchased from Accurate Chemical Scientific Corp. BaF2 windows for Fourier transform infrared microspectroscopic analysis were obtained from Spectra Tech. Rabbits were purchased from Myrtle Farm. Rabbit chows with and without 0.5% cholesterol and 2% peanut oil supplements were purchased from Harland Teklad.
Rabbit aortic smooth muscle cells were grown to confluence in 3.5-cm dishes at a seeding density of 4 × 104/ml from cell fractions isolated by collagenase digestion or from explants of normal male New Zealand White rabbit thoracic aorta fragments . Cells were further cultured in Dulbecco's modified Eagle medium (DMEM) containing 10 % fetal bovine serum (FBS) in 5% CO2 chamber until about 1.4 × 105 cells/dish were reached. The absence of alkaline phosphatase activity and the presence of NTP pyrophosphohydrolase activity of cell homogenates were consistent with previous observations with either tissue homogenates or collagenase digests [7, 18, 19, 21, 22]. For calcification assay, the Ca × P ion product in DMEM was modified to various levels by adding small aliquots of 100 mM stock solutions of CaCl2 and phosphate buffer at pH 7.5 to the media. The endogenous concentrations of both Ca and P in the media and serum were taken into consideration during the adjustment on the basis of the following information. DMEM from the supplier contains 1.8 mM Ca and 0.9 mM P corresponding to a Ca × P ion product of 1.62 mM2. A 10 % FBS contributed about 0.18 mM of Ca ions and 0.09 mM of phosphate ions to the culture media. The confluent cells were washed twice with Hank's buffer and then exposed to a 2.5-ml DMEM adjusted to a Ca × P ion product range of 4.5–9.4 mM2. Stock solutions of CaCl2 and sodium phosphate buffer at pH 7.5 were prepared fresh and filtered through 0.02 μ-filters for sterility and the exclusion of calcium carbonate particles that could be formed upon prolong storage. To prevent pH fluctuations during storage, DMEM were sealed tight with parafilm during the storage and kept in the refrigerator to minimize the loss of bicarbonate resulting from hydrolysis. The media were discarded after 1 week of storage. Sterile tubes with 2.5 ml media in each tube were kept in 5 % CO2 for 24 hrs prior to the calcification assay. The change in oxygen tension and osmalality as a result of serum depletion were neither measured nor adjusted.
Alizarin red staining for mineral deposits
After cells were exposed to modified DMEM with or without FBS for 2 hrs, the media were removed. The cells were washed twice with PBS (phosphate buffered saline) and then twice with distilled and deionized water. Unless stated otherwise, the initial Ca × P ion products of 4.6–9.37 mM2 were present in the media. A 2.5 ml of 1% alizarin red (AR) solution was then added to each dish. After 1 min, the dishes were washed twice with water, once with PBS, and photographed. Under these experimental conditions, the control cultured dishes, which contained cells exposed to culture media with 10% FBS were faintly yellowish and did not exhibit red stains. In contrast, the cells exposed to serum-free media showed bright red stains after 2 hrs of incubation.
Quantification of mineral deposited by cultured cells
After confluent cells were exposed to modified DMEM with or without serum and different Ca × P ion products for various time intervals, the cells were washed twice each with 2 ml of TBS (Tris-buffered saline, pH 7.6), followed by scraping the cell layers with 0.5 ml of 0.1 N HCl, and then mixed thoroughly using Pasteur glass pipets until the cells were finely suspended. A 10-μl aliquot of the extracts was then taken for protein determinations using a BioRad assay kit. The remaining extracts were centrifuged at 10,000 rpm in a microfuge for 10 min to collect supernatants. Aliquots of 1/5 of diluted supernatants were then taken for the determination of Ca and P content in the supernatants using a commercial Arsenazo III kit (Fisher Scientific)  and a standard molybdate-phosphate complex assay procedure (Sigma Diagnostics, Inc.), respectively.
Fourier transform infrared microspectroscopic analysis
The Ca × P ion product of DMEM was initially adjusted to 9.37 mM2. After 2 hrs of exposure to the modified culture media with or without the serum, cells were washed twice with TBS and twice with water and then scraped off from the dishes and finely suspended with Pasteur pipets. Five-μl aliquots (about 1 μg proteins) of suspensions were then spotted onto BaF2 windows for infrared analysis. The infrared spectra were obtained by scanning the deposits over a 0.6–0.8 cm path. The wavenumber at 1650 represents the protein amide peak whereas the wavenumbers at 1050–1080 indicate the mineral P phase. A Shimadzu Fourier-transform infrared microspectroscopy model AIM8400/8800 was used for analysis.
Membrane translocation assay
The assay was performed using a commercial apoptosis kit (Accurate Chemical Scientific Corp.), which measured the uptake of a specific dye by cells as a result of apoptosis-induced membrane phosphatidylserine and phosphatidylcholine translocation . The procedure was used to monitor membrane translocation as a result of serum depletion in cell culture. The assay was performed in 96-well microtiter plates. Cells were grown to confluence and followed by a thorough rinse with PBS to remove serum, and then exposed to media with or without 10% serum for 1 1/2 hrs. At the end point, each well was washed with PBS and then exposed to an apoptosis dye reagent in DMEM with or without 10% FBS for 30 min. The cells were then photographed after the removal of dyes and followed by PBS rinsing. For quantitative assay, the dye was solubilized with the provided detergent and then read at 550 nm in a BioTek EL 800 reader.
Mass spectroscopy procedure
For spectrometry analysis, calcifying vesicle fractions at protein concentration of 0.5 mg/ml were centrifuged at 250,000 × g for 20 min and then re-suspended in aliquots of water equal to the original volume of fractions. An equal volume of 1 % deoxycholate was added and mixed vigorously. After centrifugation, the precipitates were re-suspended in an aliquot of water. Proteins were precipitated by adding excess volume of alcohol. The precipitated proteins were then solubilized in small aliquots of water and then subjected to 4 M guanidine chloride denaturation and proteolysis by trypsin. Following trypsin digestion, each sample was pressure loaded on a C18 reverse phase nano-column (75 μm ID fused silica packed in-house with 9 cm of 100 Å, 5 μ, Magic C18 particles, Michrom Bioresources). Following a wash with 0.1% formic acid for 15 minutes at 0.5 μl/min, the column was mounted on the electrospray stage of an ESI IT FT ICR mass spectrometer (LTQ FT, ThermoFinnigan) and the peptides were separated on-line with a Surveyor LC with a 0 – 90 % acetonitrile gradient in 120 minutes at an approximate flow rate of 0.3 μl/min. An electrospray voltage of 1.9 kV was used, with the ion transfer temperature set to 350°C. The mass spectrometer was controlled by the Xcalibur software to perform continuously mass scan analysis on the FT followed by MS/MS scans on the ion trap of the six most intense ions, with a dynamic exclusion of two repeat scans of the same ion, 30 s repeat duration and 90 sec exclusion duration. Normalized collision energy for MS/MS was set to 35%. For data analysis all MS/MS scans were searched using the Sequest algorithm included in Bioworks 3.1 (ThermoFinnigan) using a rabbit database derived from the NCBI Nr (2006-07-08) repository.
Student's t test was used to compare the significance of the mean differences between control and experimental groups. One-way ANOVA was used to compare the significance of the differences among 3 or more groups. Three replicate experiments were used for each set of tests. For each experiment, duplicate determinations for Ca and P determinations were averaged prior to statistical analysis. ANOVA analysis was initially done globally for overall estimates and followed by Tukey analysis. A Prism software program was used for statistical analysis.
We thank N. Culley for the collection of rabbit aorta and sera, and L. Gorman for histological preparations. This work was supported by an NIH grant R01HL65287.
- Vliegenthart R, Oudkerk M, Song B, van der Kuip DAM, Hofman A, Witteman JCM: Coronary calcification detected by electron-beam computed tomography and myocardial infarction. European Heart J. 2002, 23: 1596-1603. 10.1053/euhj.2002.3240.View ArticleGoogle Scholar
- Guerin AP, London GM, Marchais SJ, Metivier F: Arterial stiffening and vascular calcification in end-stage renal disease. Nephrol Dial Transplant. 2000, 15: 1014-1021.View ArticlePubMedGoogle Scholar
- Schoen FJ, Levy BJ, Nelson AC, Bernhard WF, Nashet A, Hawley M: Onset and progression of experimental bioprosthetic heart valve calcification. Lab Invest. 1985, 52: 523-532.PubMedGoogle Scholar
- Harmey D, Hessle L, Narisawa S, Johnson KA, Terkeltaub R, Millán JL: Concerted regulation of inorganic pyrophosphate and osteopontin by Akp2, Enpp1, and Ank. An integrated model of the pathogenesis of mineralization disorders. Am J Pathology. 2004, 164: 1199-1299.View ArticleGoogle Scholar
- Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G: Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 1997, 386: 78-81. 10.1038/386078a0View ArticlePubMedGoogle Scholar
- Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS: Osteoprotegerin-deficient mice develop early onset osteoporosis and aortic calcification. Gene Dev. 1998, 12: 1260-1268.PubMed CentralView ArticlePubMedGoogle Scholar
- Hsu HHT, Tawfik O: Mechanisms of focal calcification in atherosclerosis: role of calcifying vesicles. J Investigative Medicine. 2006, 54: 402-411. 10.2310/6650.2006.06020.View ArticleGoogle Scholar
- Schinke T, Mckee MD, Karsenty G: Extracellular matrix calcification: where is the action?. Nature Genetics. 1999, 21: 150-151. 10.1038/5928View ArticlePubMedGoogle Scholar
- Schinke T, Karsenty G: Vascular calcification-a passive process in need of inhibitors. Nephrol Dial Transplant. 2000, 15: 1272-1274. 10.1093/ndt/15.9.1272View ArticlePubMedGoogle Scholar
- Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL: Bone morphogenetic expression in human atherosclerotic lesions. J Clin Invest. 1993, 91: 1800-1809.PubMed CentralView ArticlePubMedGoogle Scholar
- Demer LL, Watson KE, Bostrom K: Mechanism of calcification in atherosclerosis. Trends Cardiovasc Med. 1994, 4: 45-49. 10.1016/1050-1738(94)90025-6.View ArticlePubMedGoogle Scholar
- Virchow R: Cellular Pathology: As based upon physiological and pathological histology. 1863, 404-408. New York: Dover.Google Scholar
- Mohler ER, Gannon FH, Reynolds C, Kaplan FS: Bone formation and inflammation in calcified cardiac valves. Circulation. 2001, 103: 1522-1528.View ArticlePubMedGoogle Scholar
- Price PA, Faus SA, Williamson M: Bisphosphonate alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arteroscler Thromb Vasc Biol. 2001, 21: 817-824.View ArticleGoogle Scholar
- Miller VM, Rodgers G, Charlesworth JA, Kirkland B, Severson SR, Rasmussen TE, Yagubyan M, Rodgers JC, Cockerill FR, Folk RL, Rzewuska-Lech E, Kumar V, Farell-Baril G, Lieske JC: Evidence of nanobacterial-like structures in human calcified arteries and cardiac valves. Am J Physiol: Heart Circ Physiol. 2004, 287: H1115-H1124. 10.1152/ajpheart.00075.2004Google Scholar
- Tanimura A, McGregor DH, Anderson HC: Matrix vesicles in atherosclerotic calcification. Proc Soc Exp Biol Med. 1983, 172: 173-177.View ArticlePubMedGoogle Scholar
- Rokita E, Cichocki T, Heck D, Jarczyk L, Strzalkowski A: Calcification of aortic wall in cholesterol-fed rabbits. Atheros. 1991, 87: 183-193. 10.1016/0021-9150(91)90020-4.View ArticleGoogle Scholar
- Hsu HHT, Camacho NC, Tawfik O, Sun F: Induction of calcification in rabbit aortas by high cholesterol diets: roles of calcifying vesicles in dystrophic calcification. Atherosclerosis. 2002, 161: 85-94. 10.1016/S0021-9150(01)00623-2View ArticlePubMedGoogle Scholar
- Hsu HHT, Tawfik O, Sun F: Mechanisms of dystrophic calcification in rabbit aortas: Temporal and spatial distributions of calcifying vesicles and calcification-related structural proteins. Cardiovascular Path. 2004, 13: 3-10. 10.1016/S1054-8807(03)00093-0.View ArticleGoogle Scholar
- Rattner A, Sabido O, Le J, Vico L, Massoubre C, Frey J, Chamson A: Mineralization and alkaline phosphatase activity in collagen lattices populated by human osteoblasts. Calcif Tissue Int. 2000, 66: 35-42. 10.1007/s002230050007View ArticlePubMedGoogle Scholar
- Hsu HHT, Camacho N: Isolation of calcifying vesicles from human atherosclerotic aortas. Atherosclerosis. 1999, 143: 353-362. 10.1016/S0021-9150(98)00322-0View ArticlePubMedGoogle Scholar
- Hsu HHT, Camacho N, Sun F, Tawfik O, Aono H: Isolation of calcifying vesicles from aortas of rabbits fed high cholesterol diets. Atherosclerosis. 2000, 153: 337-348. 10.1016/S0021-9150(00)00425-1View ArticlePubMedGoogle Scholar
- Proudfoot D, Skepper JN, Hegyi L, Bennett M, Shanahan CM, Weissberg PL: Apoptosis regulates human vascular calcification in vitro: Evidence for initiation of vascular calcification by apoptotic bodies. Circulation Res. 2000, 87: 1055-1062.View ArticlePubMedGoogle Scholar
- Kisseleva MV, Cao L, Majerus PW: Phosphoinositide-specific inositol polyphosphate 5-phosphatase IV inhibits Akt/PKB phosphorylation and leads to apoptotic cell death. J Bio Chem. 2002, 277: 11199-11203.View ArticleGoogle Scholar
- Kirsch T, Harrison G, Golub EE, Nah H-D: The roles of annexins and types II and X collagen in matrix vesicle-mediated mineralization of growth plate cartilage. J Biol Chem. 2000, 275: 35577-35583. 10.1074/jbc.M005648200View ArticlePubMedGoogle Scholar
- Somogyi E, Petersson μ, Hultenby K, Wendel M: Calreticulin-an endoplasmic reticulum protein with calcium-binding activity is also found in the extracellular matrix. Matrix Biol. 2003, 22: 179-191. 10.1016/S0945-053X(02)00117-8View ArticlePubMedGoogle Scholar
- Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell. 1992, 69: 11-25. 10.1016/0092-8674(92)90115-SView ArticlePubMedGoogle Scholar
- Pereira L, Lee SY, Gayraud B, Andrikopoulos K, Shapiro SD, Bunton T, Biery NJ, Dietz HC, Sakai LY, Ramirez F: Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-l. Proc Natl Acad Sci USA. 1999, 96: 3819-3823. 10.1073/pnas.96.7.3819PubMed CentralView ArticlePubMedGoogle Scholar
- Kadkol SS, Lin AY, Barak V, Kalickman I, Leach L, Valyi-Nagy K, Majumdar D, Setty S, Maniotis AJ, Folberg R, Pe'er J: Osteopontin Expression and Serum Levels in Metastatic Uveal Melanoma: A Pilot Study. Inv Ophth Vis Sce. 2006, 47: 802-806. 10.1167/iovs.05-0422.View ArticleGoogle Scholar
- Braam LAJLM, Dissel P, Gijsbers BLMG, Spronk HMH, Hamulyak K, Soute BAM, Debie W, Vermeer C: Assay for human matrix Gla Protein in serum: Potential applications in the cardiovascular field. Artereioscler Thromb Vasc Biol. 2000, 20: 1257-1261.View ArticleGoogle Scholar
- Mollman JE, Pleasure DE: Calcium transport in human inside-out erythrocyte vesicles. J Biol Chem. 1980, 255: 569-574.PubMedGoogle Scholar
- Warren HB, Lausen NC, Segre GV, el-Hajj G, Brown EM: Regulation of calciotropic hormones in vivo in the New Zealand white rabbit. Endocrinology. 1989, 125: 2683-2690.View ArticlePubMedGoogle Scholar
- Fratzl-Zelman N, Fratzl P, Horandner H, Grabner B, Varga F, Ellinger A, Klaushofer K: Matrix mineralization in MC3T3-E1 cell cultures initiated by β-glycerophosphate pulse. Bone. 1998, 23: 511-520. 10.1016/S8756-3282(98)00139-2View ArticlePubMedGoogle Scholar
- Wada T, McKee MD, Steitz S, Giachelli CM: Calcification of vascular smooth muscle cell cultures. Circ Res. 1999, 84: 166-178.View ArticlePubMedGoogle Scholar
- Fedde KN: Human osteosarcoma cells spontaneously release matrix vesicle-like structures with the capacity to mineralize. Bone Mineral. 1992, 17: 145-151. 10.1016/0169-6009(92)90726-T.View ArticlePubMedGoogle Scholar
- Price PA, Williamson MK, Nguyen TMT, Than TN: Serum levels of the fetuin-mineral complex correlate with artery calcification in the rat. J Biol Chem. 2004, 279: 1594-1600. 10.1074/jbc.M305199200View ArticlePubMedGoogle Scholar
- Steitz SA, Speer MY, McKee MD, Liaw L, Almeida M, Yang H, Giachelli M: Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Path. 2002, 161: 2035-2046.PubMed CentralView ArticlePubMedGoogle Scholar
- Rasmussen LM, Tarnow L, Hansen TK, Parving H-H, Flyvberg A: Plasma osteoprotegerin levels are associated with glycaemic status, systolic blood pressure, kidney function and cardiovascular morbidity in type 1 diabetic patients. Eur J Endo. 2006, 154: 75-81. 10.1530/eje.1.02049.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.